Trial Profile
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs PN 2034 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Mar 2008 New trial record.